Tissue engineering & nanocarriers: a game-changer in healing cartilage lesions
Future research should prioritize in vivo validation of bio-activated scaffolds, comprehensive assessment of long-term functional outcomes, and strategies to facilitate clinical translation of combined nanocarrier-scaffold platforms. Further investigation into both patient-specific and off-the-shelf regenerative approaches is essential to overcome current translational barriers.
Authors
- Giovanna Della Porta (ORCID: https://orcid.org/0000-0002-1426-0159)
- Erwin Pavel Lamparelli (ORCID: https://orcid.org/0000-0001-9700-5809)
- Nicola Maffulli
Institutions
- University of Salerno (IT)
- Mile End Hospital (GB)
- Azienda Ospedaliera Sant'Andrea (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- British Medical Bulletin
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1093/bmb/ldag001
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00